Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus dienogest for bleeding and pain in adenomyosis
IRCT20240908062973N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in adenomyosis comparing Letrozole with Dienogest (2 arms). Primary endpoints: Amount of menstrual bleeding and Menstrual pain. Started Nov 2024; status: completed.
02
Drugs
letrozoledienogest
03
Conditions
adenomyosis
Beyond the preview
Go deeper on IRCT20240908062973N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240908062973N1.